Browse By Person: McPherson, Stephen
|Up a level|
Group by: Item Type | Date
Number of items: 15.
Bianco, Joseph, McPherson, Stephen, Wang, Hong, Prins, Gail, & Risbridger, Gail (2006) Transient neonatal estrogen exposure to estrogen-deficient mice (Aromatase Knockout) reduces prostate weight and induces inflammation in late life. The American Journal of Pathology: cellular and molecular biology of disease, 168(6), pp. 1869-1878.
Simanainen, Ulla, Allan, Charles, Lim, Patrick, McPherson, Stephen, Jimenez, Mark, Zajac, Jeffrey, et al. (2007) Disruption of prostate epithelial androgen receptor impedes prostate lobe-specific growth and function. Endocrinology, 148(5), pp. 2264-2272.
McPherson, Stephen, Ellem, Stuart, Simpson, Evan, Patchev, Vladimir, Fritzemeier, Karl-Heinrich, & Risbridger, Gail (2007) Essential role for estrogen receptor Beta in stromal-epithelial regulation of prostatic hyperplasia. Endocrinology, 148(2), pp. 566-574.
Risbridger, Gail, Ellem, Stuart, & McPherson, Stephen (2007) Estrogen action on the prostate gland: a critical mix of endocrine and paracrine signaling. Journal of Molecular Endocrinology, 39(3), pp. 183-188.
Cowin, Prue, Foster, Paul, Pedersen, John, Hedwards, Shelley, McPherson, Stephen, & Risbridger, Gail (2008) Early-onset endocrine disruptor-induced prostatitis in the rat. Environmental Health Perspectives, 116(7), pp. 923-929.
McPherson, Stephen, Ellem, Stuart, & Risbridger, Gail (2008) Estrogen-regulated development and differentiation of the prostate. Differentiation, 76(6), pp. 660-670.
Ricke, William, McPherson, Stephen, Bianco, Joseph, Cunha, Gerald, Wang, Yuzhuo, & Risbridger, Gail (2008) Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling. The FASEB Journal, 22(5), pp. 1512-1520.
McPherson, Stephen, Hussain, Shirin, Balanathan, Preetika, Hedwards, Shelley, Niranjan, Birunthi, Grant, Michael, et al. (2010) Estrogen receptor-Beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNF-alpha mediated. Proceedings of the National Academy of Sciences of the United States of America, 107(7), pp. 3123-3128.
Bajpai, Anurag, Simm, Peter, McPherson, Stephen, Russo, Vincenzo, Azar, Walid, Wark, John, et al. (2010) Peripubertal aromatase inhibition in male rats has adverse long-term effects on bone strength and growth and induces prostatic hyperplasia. Journal of Endocrinology, 207(1), pp. 27-34.
Simanainen, Ulla, McNamara, Keely, Gao, Yan Ru, McPherson, Stephen, Desai, Reena, Jimenez, Mark, et al. (2011) Anterior prostate epithelial AR inactivation modifies estrogen receptor expression and increases estrogen sensitivity. American Journal of Physiology: Endocrinology and Metabolism, 301(4), E727-E735.
Soekmadji, Carolina, Ruelcke, Jayde E., Wang, Chenwei, Riches, James D., McPherson, Stephen, Russell, Pamela, et al. (2015) Extracellular vesicles mediate paracrine signalling in androgen deprived prostate cancer. In 2nd Prostate Cancer World Congress, 17-21 August 2015, Cairns Convention Centre, Cairns, Qld.
Kryza, Thomas, Tevz, Gregor, McPherson, Stephen, Lehman, Melanie, Nelson, Colleen, & Clements, Judith (2015) Modulation of protease expression in prostate cancer cells after androgen deprivation. In 2nd Prostate Cancer World Congress, 17-21 August 2015, Cairns Convention Centre, Cairns, Qld.
Volpert, Marianna, Tse, Brian W.C., Stylianou, Nataly, Ratther, Ellca, McPherson, Stephen, Costa, Taylor, et al. (2015) Targeting neuropilin-1 to inhibit prostate cancer invasion and metastasis. In 2nd Prostate Cancer World Congress, 17-21 August 2015, Cairns Convention Centre, Cairns, Qld.
Soekmadji, Carolina, Riches, James D., Russell, Pamela J., Ruelcke, Jayde E., McPherson, Stephen, Wang, Chenwei, et al. (2016) Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer. Oncotarget. (In Press)
Tevz, Gregor, McGrath, Sean, Demeter, Ryan, Magrini, Vincent, Jeet, Varinder, Rockstroh, Anja, et al. (2016) Identification of a novel fusion transcript between human relaxin-1 (RLN1) and human relaxin-2 (RLN2) in prostate cancer. Molecular and Cellular Endocrinology, 420, pp. 159-168.